Core Laboratories (CLB) Receivables (2022 - 2026)

Core Laboratories has reported Receivables for 5 years, with the latest figure at $108.3 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 8.08% year-over-year to $108.3 million; the trailing twelve-month figure through Mar 2026 stood at $108.3 million (down 8.08% YoY), and the FY2025 full-year result was $113.5 million, up 1.25% from the prior year.
• Receivables for Q1 2026 stood at $108.3 million, down from $113.5 million in the prior quarter.
• The five-year high for Receivables was $118.2 million in Q3 2024, with the low at $105.2 million in Q3 2023.
• Historically, Receivables has averaged $112.3 million across 5 years, with a median of $112.1 million in 2024.
• Annual changes were most pronounced in 2024 — Receivables grew 12.35% — and 2026, when it fell 8.08%.
• Core Laboratories' Receivables stood at $108.1 million in 2022, then gained by 2.39% to $110.6 million in 2023, then advanced by 1.34% to $112.1 million in 2024, then climbed by 1.25% to $113.5 million in 2025, then decreased by 4.63% to $108.3 million in 2026.
• The last three Receivables figures came in at $108.3 million (Q1 2026), $113.5 million (Q4 2025), and $111.4 million (Q3 2025), per Business Quant data.